SuperworthIGC Pharma shares outstanding IGC
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 100.3M
- On a year earlier
- +32.0%
- more shares
IGC Pharma had 100.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 32.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 79.7M | −14% |
| FY2025 | 93M | +45% |
| FY2024 | 64.3M | +42% |
| FY2021 | 45.2M | +15% |
| FY2020 | 39.3M | −1% |
| FY2019 | 39.5M | +30% |
| FY2018 | 30.4M | +51% |
| FY2017 | 20.2M | +20% |
| FY2016 | 16.9M | −22% |
| FY2015 | 21.8M | +126% |
| FY2014 | 9.6M | −3% |
| FY2013 | 9.9M | +84% |
| FY2012 | 5.4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 100.3M | +32% | |
| Q1 FY26 | 98.2M | +35% | |
| Q4 FY25 | 93M | +45% | |
| Q3 FY25 | 90.5M | +42% | |
| Q1 FY25 | 83M | +14% | |
| Q4 FY25 | 79.7M | +24% | |
| Q3 FY25 | 77.6M | +22% | |
| Q2 FY25 | 76M | +40% | |
| Q1 FY25 | 72.8M | n/a | |
| Q4 FY24 | 64.3M | n/a | |
| Q3 FY24 | 63.7M | n/a | |
| Q2 FY24 | 54.3M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on IGC Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.